- >=99.4 HPLCHPLC / MSIn stock
Research compound
Cagrilintide
Cagrilintide is a fatty acid-acylated amylin analog engineered for extended pharmacokinetic half-life via C18-mediated albumin binding, distinguishing it from native amylin in biochemical assays. Its receptor specification covers the AMY1-3 class — heteromeric calcitonin receptor / receptor activity-modifying protein complexes — with characterization concentrated in hypothalamic and hindbrain neuronal culture preparations. Published receptor pharmacology programs have examined cagrilintide within the CagriSema dual-agonist framework alongside GLP-1R engagement. Supplied lyophilized for in vitro research use only.
Specification
- CAS
- 1415456-99-3
- Molecular weight
- 4409.01 g/mol
- Formula
- C194H312N54O59S2
- Purity
- >=99.4 HPLC
- Storage
- -20 °C, lyophilized
Size
Research notes
What is Cagrilintide?
Cagrilintide is a synthetic research compound studied in laboratory settings. It has molecular formula C194H312N54O59S2, a molecular weight of 4409.01 g/mol, CAS 1415456-99-3. It is intended for in vitro research use only and is not for human or animal use.
What purity is Valitec Peptides's Cagrilintide?
Valitec Peptides supplies Cagrilintide at >=99.4% purity, verified by third-party HPLC analysis. A certificate of analysis is available on request.
How is Cagrilintide supplied?
Cagrilintide is supplied as a lyophilized powder in sealed research-grade vials, stored -20 °C, lyophilized, intended for in vitro and laboratory research use only.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic use.